Hydroxyzine pamoate is not addictive. It has no potential for abuse, carries no risk of physical dependence, and is not classified as a controlled substance by the DEA. This is one of the main reasons doctors prescribe it for anxiety instead of drugs like benzodiazepines, which do carry significant addiction risks.
Why It’s Not Addictive
Addiction typically involves drugs that activate the brain’s reward system, the dopamine-driven circuitry that reinforces pleasure-seeking behavior. Hydroxyzine doesn’t work on that system at all. It’s a first-generation antihistamine that blocks histamine receptors in the brain. That blocking action produces sedation and calm, which is why it helps with anxiety and itching, but it doesn’t create the euphoria or reinforcing “high” that drives compulsive use.
This makes it fundamentally different from benzodiazepines like alprazolam (Xanax), which act on GABA receptors and carry real risks of misuse, dependence, and withdrawal. Hydroxyzine pamoate has no DEA scheduling whatsoever, while benzodiazepines are Schedule IV controlled substances.
No Withdrawal or Rebound Anxiety
A controlled clinical trial testing hydroxyzine at 50 mg per day for generalized anxiety found that patients who abruptly stopped taking the drug experienced no rebound anxiety and no withdrawal symptoms. The anxiolytic effect held steady over the four-week study period and didn’t collapse when the medication was discontinued. This is a meaningful distinction: benzodiazepines can cause severe withdrawal, including seizures, if stopped suddenly after regular use.
That said, some people notice the return of their baseline anxiety after stopping hydroxyzine. This isn’t withdrawal. It’s the original anxiety coming back once the medication is no longer suppressing it. The difference matters: withdrawal means your body developed a physiological need for the drug. Returning symptoms simply mean the underlying condition still exists.
Does Tolerance Build Over Time?
In clinical studies, hydroxyzine’s anxiety-relieving effect remained consistent from the first week through four weeks of treatment without requiring dose increases. However, long-term data beyond a few months is limited. The World Federation of Societies of Biological Psychiatry notes that experience with long-term hydroxyzine treatment is lacking, which is one reason guidelines recommend it mainly when other options haven’t worked or weren’t tolerated.
Some people do report that the sedating effect feels less intense after taking it regularly for a while. Whether that represents true pharmacological tolerance or simply getting used to the feeling isn’t well established. If you feel like it’s becoming less effective, that’s worth discussing with whoever prescribed it rather than increasing your dose on your own.
Why Doctors Prescribe It for People in Recovery
Hydroxyzine’s lack of addiction potential makes it especially useful for patients who have a history of substance use disorder. When someone in recovery from alcohol or opioid dependence develops anxiety, prescribing a benzodiazepine introduces a new addiction risk. Hydroxyzine offers a way to manage anxiety without that concern. Researchers have described it as having “a low liability for abuse” alongside “a benign side effect profile,” and it has been studied as part of treatment protocols for opioid withdrawal specifically because it avoids the dependence risks of alternatives like methadone or buprenorphine.
What It’s Prescribed For
Hydroxyzine pamoate (sold under the brand name Vistaril) is FDA-approved for two main uses: anxiety relief and itch control. For anxiety in adults, the labeled dose ranges from 50 to 100 mg taken four times daily. For itching caused by allergic conditions, the typical dose is 25 mg three to four times daily. In practice, many doctors prescribe it at lower doses or on an as-needed basis, particularly for situational anxiety or sleep.
International treatment guidelines give hydroxyzine a solid evidence rating for generalized anxiety disorder, placing it in the same effectiveness tier as some benzodiazepines in head-to-head trials. One three-arm study found no difference in effectiveness between hydroxyzine and a benzodiazepine for generalized anxiety. However, guidelines also note that hydroxyzine doesn’t help with panic disorder, social anxiety, PTSD, or OCD, and it has no antidepressant effect.
Side Effects to Expect
The most common side effect is drowsiness, affecting roughly 14% of people in clinical trials. Headache, fatigue, and dry mouth each occur in 1% to 10% of users. The sedation is the primary reason hydroxyzine isn’t a first-line anxiety treatment for everyone. Daytime sleepiness can interfere with driving, work, and concentration, particularly when you first start taking it. Most people find the sedation is strongest in the first few days and becomes more manageable over time.
These side effects are generally mild and resolve when the medication is stopped. There are no known dangerous interactions with the brain’s reward pathways, no cravings associated with discontinuation, and no pattern of dose escalation in clinical use. For people specifically worried about taking something habit-forming for their anxiety, hydroxyzine pamoate is one of the lowest-risk options available.